Lymphocytes play a major role in host defense against Aspergillus, but little is known about the contribution of dendritic cells (DC) to antifungal immunity in humans. We have observed that DC derived from normal volunteers phagocytose heat-killed A. fumigatus conidia. Following 24 h of exposure to the fungus, DC displayed an increase in the mean fluorescence intensity of HLA-DR, CD80, and CD86, and an increase in the percentage of CD54 + cells. These DC also displayed increased production of IL-12. DC derived from CD34 + progenitors or monocytes stimulated autologous lymphocytes to proliferate and produce high levels of interferon-␥, but not interleukin-10, in response to fungal antigen. DC generated from CD34 + progenitors collected prior to autologous or allogeneic stem cell transplantation also partially restored the in vitro antifungal proliferative response of lymphocytes obtained from patients 1 month after transplantation. These results suggest that DC are important to host-response to A. fumigatus, and that ex vivo-generated DC might be useful in restoring or enhancing the antifungal immunity after hematopoietic stem cell transplantation. Bone Marrow Transplantation (2001) 27, 647-652. Keywords: fungi; dendritic cell; immune reconstitution; Candida; Aspergillus The ubiquitous mould Aspergillus rarely causes disease in healthy individuals but poses a serious threat to hematopoietic stem cell transplant recipients. [1] [2] [3] It is the most common etiology of non-Candida fungal infections occurring in these patients, and the case-fatality rate for invasive aspergillosis exceeds 80%. Although prolonged neutropenia is a well-established risk factor for Aspergillus infections, the majority of infections in the allogeneic setting become clinically evident well after engraftment, 2 suggesting that cell-mediated immunity plays an important role in protec-
The ubiquitous mould Aspergillus rarely causes disease in healthy individuals but poses a serious threat to hematopoietic stem cell transplant recipients. [1] [2] [3] It is the most common etiology of non-Candida fungal infections occurring in these patients, and the case-fatality rate for invasive aspergillosis exceeds 80%. Although prolonged neutropenia is a well-established risk factor for Aspergillus infections, the majority of infections in the allogeneic setting become clinically evident well after engraftment, 2 suggesting that cell-mediated immunity plays an important role in protec- tion against this pathogen. Indeed, animal studies demonstrated that a Th1 response was associated with resistance to induction of experimental Aspergillus infection, 4 and methods stimulating a Th1 response were successful in inducing anti-Aspergillus immunity. 5 We 6 and others 7 have reported that a substantial proportion of blood and marrow transplant recipients have a deficiency in the number of circulating dendritic cells (DC) in the early post-transplant period. To overcome the potential effects of DC deficiency on immune reconstitution post transplant, DC-based vaccines have been used to induce T cell-mediated immunity to tumor early after transplantation. 8 However, despite the importance of DC in immunity, there is virtually no information regarding the role of human DC in resistance to aspergillosis. We have therefore evaluated the phagocytic capacity of human DC for A. fumigatus conidia, the cytokine response of human DC after exposure to A. fumigatus conidia, and the immunostimulatory competence of A. fumigatus conidia-pulsed DC for autologous lymphocytes from blood stem cell transplant recipients. The results of our studies suggest that DC might be useful in a new approach to prevention and treatment of invasive aspergillosis after hematopoietic stem cell transplantation.
Materials and methods

Generation of CD34-derived dendritic cells (34DC)
Peripheral blood stem cells collected by apheresis from filgrastim-mobilized normal volunteers or patients with breast cancer were debulked by separation over Buoyant Density Solution 60 gradient (Activated Cell Therapy, Mountain View, CA, USA) as described previously.
9 CD34 + cells from the very light density fraction of the gradient were purified by immunomagnetic selection using a CD34 Isolation Kit and MACS VS + separation columns (Miltenyi Biotec, Auburn, CA, USA). Two rounds of positive selection were performed to maximize the purity of CD34 + cells, which ranged from 95 to 98% as determined by flow cytometric analysis. The CD34 − leukocytes from the effluent were cryopreserved in 90% human AB serum plus 10% DMSO for use later as a source of autologous lymphocytes. Human specimens used in these studies were obtained with approval of the Institutional Review Board.
Bone Marrow Transplantation
CD34
+ progenitors were cultured at a concentration of 1-5 × 10 5 /ml in RPMI 1640 medium containing 10 mm Hepes buffer, 100 g/ml streptomycin, 100 U/ml penicillin, 2 mm glutamine, 20 m 2-mercaptoethanol, 1 mm sodium pyruvate, and 0.1 mm nonessential amino acids (complete medium). This medium was further supplemented with 10% FCS, 50 ng/ml GM-CSF, 5 ng/ml IL-4, 200 U/ml TNF-␣ and 50 ng/ml stem cell factor (SCF; R&D Systems, Minneapolis, MN, USA) to promote generation of DC. In some studies, SCF was replaced with FLT3 ligand (FL) 50 ng/ml, kindly provided by Immunex (Seattle, WA, USA). The cells were fed with complete RPMI containing only GM-CSF every 3-4 days for 9-12 days. On phenotypic analysis (see below), CD34-derived DC were 63.7 ± 4.8% lin − DR + , 4.0 ± 0.6% CD80 + , 27.5 ± 13.8% CD86 + , 6.5 ± 0.9% CD14 + , and 4.0 ± 1.7% CD1a + .
Preparation of monocytes (Mo) and monocyte-derived dendritic cells (MoDC)
In some experiments a portion of the apheresis sample was separated on a Ficoll-Hypaque density gradient, and the mononuclear cells were used to generate MoDC using a modification of techniques described previously. 10, 11 Briefly, the mononuclear cells were suspended at a concentration of 10 7 /ml in RPMI 1640 medium supplemented with 10% FCS and cultured in plastic tissue culture dishes for 2 h at 37°C in 5% CO 2 . This adherent population of Mo was found to consist of 74.7 ± 4.9% CD14
+ cells as analyzed by flow cytometry. For generation of MoDC, the adherent cells were cultured in RPMI containing 50 ng/ml GM-CSF and 50 ng/ml IL-4 for 9 days with feeding every 2 days. TNF-␣ was added at a dose of 200 U/ml on the 5th day of culture. Phenotype analysis showed that monocytederived DC were 87. 4 
Preparation of fungi
A. fumigatus conidia and C. albicans blastoconidia were killed by heating in a water bath at 100°C for 1 h, washed three times in PBS, and stored at 4°C. 12 The efficiency of this treatment was verified by the failure of the heatexposed fungi to grow when cultured for 10 days in Sabouraud dextrose agar. Before use, the fungi were washed again in medium and resuspended at the appropriate concentration.
Electron microscopy
Phagocytosis was evaluated by transmission electron microscopy.
13 34DC were mixed with heat-killed A. fumigatus conidia at a 1:10 DC:conidia ratio and incubated for 24 h at 37°C. The cells were then collected, washed, fixed in 2% glutaraldehyde and processed for analysis by transmission electron microscopy. Thin sections were stained with uranil acetate and lead citrate and then examined by transmission electron microscopy.
Flow cytometry
The phenotype of leukocyte populations was determined by immunofluorescence using fluorochrome-conjugated monoclonal antibodies recognizing CD1a, CD3, CD11b, CD11c, CD16, CD19, CD20, CD54, and HLA-DR (Caltag, Burlingame, CA, USA); CD56 and CD80 (Becton Dickinson Immunocytometry Systems, San Jose, CA, USA); or CD86 (Pharmingen, Sunnyvale, CA, USA). Controls included fluor-conjugated isotype-matched antibodies that were nonreactive to human lymphocytes (Caltag and Becton Dickinson). Surface staining was performed as described previously, 12 and the cells were analyzed using a FACScan flow cytometer and Consort 30 or Lysys II software (Becton Dickinson). DC were characterized by the absence of lineage (lin)-associated surface molecules (CD3, CD11b, CD14, CD16, CD19, CD20 and CD56) and the presence of HLA-DR using a flow cytometric technique described previously. 14 
Measurement of cytokines
DC were suspended to a concentration of 10 6 /ml and exposed to heat-killed A. fumigatus or C. albicans (1:10 DC:fungus ratio), or to medium alone (control). After 24 h, the supernatants were collected, stored at −20°C, and tested for IL-12 at a later time using an ELISA assay (Biosource International, Camarillo, CA, USA) that detected both the p40 and p70 subunits. The lower limit of detection of the assay was 1 pg/ml. For detection of cytokine production in lymphocyte stimulation experiments, lymphocytes were cultured for 6 days under conditions identical to those described below in the proliferation assays. Supernatants were collected after 6 days of culture, stored, and tested later for the presence of IFN-␥ and IL-10 using ELISA assays (Biosource International) with lower limits of detection of 4 pg/ml and 5 pg/ml, respectively.
Lymphocyte proliferation assay
Lymphocytes autologous to the DC were isolated from the effluent of the CD34 selection column. The cells were first separated by plastic adherence to remove Mo. Plastic-nonadherent cells were then passed through nylon wool columns to further deplete them of Mo and B cells. The resulting lymphocytes were 92.2 ± 1.9% CD3 + as evaluated by flow cytometry. Proliferation of lymphocytes in response to fungal antigens was determined by tritiated thymidine uptake.
12 34DC, MoDC or Mo were irradiated (3000 cGy) prior to use as antigen-presenting cells (APC). Lymphocytes were cultured in RPMI medium supplemented with 5% human AB serum in flat-bottomed 96-well plates at 1.5 × 10 5 cells/well with autologous APC at a lymphocyte:APC ratio of 8:1. Heat-killed A. fumigatus conidia or C. albicans blastoconidia were added to the designated wells at a 1:10 lymphocyte:fungus ratio, and the plates were incubated for 6 days at 37°C in 5% CO 2 . Wells containing irradiated DC alone, lymphocytes alone, and lymphocytes plus DC without antigen were included as controls. Tritiated thymidine (0.5 Ci/well) was added dur-ing the last 18 h of culture. The cells were harvested on to glass fiber paper, and the radioactivity counted in a ␤-scintillation counter. The results were expressed as the mean counts per minute (c.p.m.) of triplicate samples.
Statistical analyses
The immunophenotype, proliferative response, and cytokine production after stimulation of lymphocytes with fungi was compared to control results using the t-test. The paired t-test was used when analyzing data combined from multiple donors. Two-sided P values Ͻ0.05 were considered significant.
Results
Phagocytosis of A. fumigatus by human DC
To determine the phagocytic capacity of DC for large particles, we investigated whether CD34-derived DC (34DC) phagocytosed whole A. fumigatus conidia. As seen in Figure 1 , 34DC cocultured for 24 h with heat-killed fungus contained A. fumigatus conidia within membrane-lined cytoplasmic vesicles. These cells displayed typical DC morphology (ie multiple elongated cytoplasmic processes and lobulated nuclei), with cytoplasmic and nuclear membranes intact and no evidence of damage to organelles. Similar results were achieved using C. albicans blastoconidia. Thus, DC could take up fungi without apparent adverse effect to the cells. A similar analysis using live fungi was not possible because of fungal overgrowth of cultures after the 24 h incubation period, indicating that 34DC do not prevent growth of viable fungi.
Activation of DC in response to A. fumigatus
To determine whether exposure to A. fumigatus induced activational changes in DC, 34DC were cultured with heatkilled fungal conidia for 24 h and analyzed by flow cytometry for surface expression of HLA-DR, CD80, CD86, CD54 Bone Marrow Transplantation and CD11c. As shown in Table 1 , there was a significant increase in the percentage of CD54 + DC upon exposure to A. fumigatus, but the proportions of DC expressing HLA-DR, CD80, CD86 and CD11c were essentially unchanged. However, within the subpopulation of DC expressing these activation markers, the MFIs for HLA-DR, CD80 and CD86 were higher following coculture with fungal conidia despite the fact that the percentage of marker-positive cells had not increased (Table 1) . These results are consistent with completion of maturation of DC upon exposure to fungal conidia.
A. fumigatus stimulation of cytokine production in DC cultures or DC plus lymphocyte cocultures
Since only a type-1 polarization of the immune response has been associated with protection against experimental aspergillosis, we investigated the effect of A. fumigatus on the cytokine profile of stimulated DC and lymphocytes. As shown in Table 2 , stimulation of 34DC for 24 h with heatkilled fungal conidia resulted in a significant increase in IL-12 in the supernatant in comparison to DC cultured without fungi. Furthermore, IFN-␥ was clearly increased in supernatant from cocultures of lymphocytes with irradiated autologous DC in the presence of A. fumigatus (Table 2) . In contrast, IL-10 was not detected whether or not fungal conidia were added to the cultures. Neither IFN-␥ nor IL-10 was detected in supernatant from cultures of lymphocytes and fungi without DC or from cultures of DC and fungi without lymphocytes. Thus, it appears that A. fumigatus stimulation of lymphocytes through autologous DC results in a type-1 polarization.
DC stimulated the proliferative response to A. fumigatus by normal donor lymphocytes
We next examined whether DC could mediate the antifungal proliferative response of autologous lymphocytes from normal volunteers. Positively-selected CD3 + lymphocytes were cultured as shown in Table 3 , and the proliferative response was measured by tritiated thymidine incorporation. The proliferative response to A. fumigatus increased significantly for five of six donors using CD34-derived DC and for three of three donors using monocyte-derived DC in comparison to cultures without fungal conidia. In contrast, when monocytes were used as the APC in the culture, there was no significant response to A. fumigatus in any of five donors. These results demonstrate that ex vivo-generated DC could mediate stimulation of normal lymphocytes to fungi.
DC enhance the proliferative response to A. fumigatus by peripheral blood mononuclear cells (PBMC) from allogeneic or autologous blood stem cell transplant recipients
To determine whether DC had any effect on the in vitro lymphocyte response to A. fumigatus for transplant recipients, we measured thymidine uptake in PBMC collected 1 month after transplantation and cocultured as described in Table 4 with APC derived from the apheresis component Lymphocytes were cultured for 6 days with autologous dendritic cells in the absence or presence of heat-killed fungi. Supernatants from these cultures were tested for IFN-␥ using ELISA. CD34-derived dendritic cells were cultured for 24 h with or without heat-killed fungi (1:10 DC:fungal conidia ratio). Supernatants were collected and tested for IL-12 by ELISA. Results reported in pg/ml. Underlined values were significantly increased compared to controls (no fungi) (P Ͻ 0.05). Nylon wool-nonadherent lymphocytes (LY) from normal volunteers were cultured for 6 days either alone, with irradiated dendritic cells (DC) at an 8:1 ratio, irradiated monocytes (Mo) at an 8:1 ratio, or with irradiated DC or Mo and heat-killed fungi (1:10 LY:fungal conidia ratio). Values represent the mean c.p.m. of replicate cultures. The s.e. of the mean was Ͻ20%. The c.p.m. of Mo, CD34-derived DC (34DC), and monocyte-derived DC (MoDC) incubated alone or with fungal conidia but no LY were Ͻ85. NT = not tested. Underlined values were significantly different from controls (no fungi) (P Ͻ 0.05).
used for transplantation. Thus, PBMC from allogeneic transplant recipients were cocultured with DC derived from the donor blood stem cell harvest, and PBMC from autologous transplant recipients were cocultured with DC derived from their own blood stem cell harvest. DC enhanced the response to A. fumigatus for two of three allogeneic transplant patients and one of the 2 autologous transplant patients (Table 4) . However, the consistency of enhancement of the proliferative response appeared to be greatest when DC were derived from CD34 + cells using GM-CSF, TNF-␣ and FLT ligand. Thus, DC could enhance the in vitro proliferative response to A. fumigatus even when PBMC were collected only 1 month after transplantation when patients were still highly immunocompromised.
651 Table 4 Dendritic cell-mediated stimulation of transplant recipient lymphocyte proliferative response Peripheral blood mononuclear cells (PBMC) were obtained 1 month after allogeneic (patients 1-3) or autologous (patients 4 and 5) blood stem cell transplantation and cultured as described in Table 3 
Discussion
Although the immune response to Candida in hematopoietic stem cell transplant recipients has been studied extensively, 15 in vitro measures of immunity to Aspergillus are less well understood. In a murine model described recently, 4, 5, 16, 17 Cenci et al noted that mouse strains mounting a Th1 response were resistant to experimental invasive aspergillosis, while those with a predominantly Th2 response succumbed to the infection. In addition, we reported previously that A. fumigatus conidia induced a Th1 response in vitro using peripheral blood mononuclear cells from normal volunteers, 12 suggesting that a Th1 response can also be induced in humans. We have now evaluated the role of DC in this response.
The first step in induction of a cell-mediated immune response is uptake and processing of antigen by the APC. DC take up antigen by receptor-mediated internalization, pinocytosis and phagocytosis. 18, 19 DC have been observed to phagocytose whole bacteria, but whether large particles, such as whole fungal conidia, could be taken up was unknown. Moreover, toxic metabolites of A. fumigatus are known to inhibit phagocytosis, 20 raising further doubts about the phagocytic capacity of DC for this fungus. However, we have shown here that DC generated ex vivo take up A. fumigatus conidia without apparent adverse effects to the cells.
Exposure of immature DC to antigen has been shown to result in the final stages of maturation with loss of phagocytic capacity and upregulation of the major histocompatibility antigens, costimulatory molecules and adhesion molecules involved in antigen presentation and T cell Bone Marrow Transplantation stimulation. 21 In our study, exposure of DC to A. fumigatus did result in expression of the adhesion molecule CD54 by a higher proportion of cells, but the proportion of cells expressing the other activation markers remained relatively constant. However, the mean fluorescence intensities for the class II molecule and the costimulatory molecules CD80 and CD86 were increased on cells expressing these molecules. Moreover, IL-12 was produced by the fungal-stimulated DC, even in the absence of lymphocytes. This is in contrast to the known pathway of IL-12 production resulting from the interaction of CD40 + DC with CD40-ligand-bearing T lymphocytes, 22 but similar to the reported rapid T lymphocyte-independent stimulation of IL-12 production by murine DC by microbes or microbial products. 23 Thus, A. fumigatus conidia activated ex vivo-generated DC and resulted in a DC1-type polarization.
In the murine models of invasive aspergillosis, although the resistant phenotype was IL-12-dependent, the protective effect also required IFN-␥ and the absence of Th2-type cytokines. 5, 17 In our experiments, IFN-␥, the Th1-type cytokine, was produced by lymphocytes from normal volunteers when exposed to A. fumigatus only in the presence of DC, and IL-10, a Th2-type cytokine, was not detectable in supernatants from these cultures. In addition, there was a proliferative response to A. fumigatus by normal donor lymphocytes only in the presence of DC. These results suggest that the ex vivo-generated DC played an active role in a Th1 lymphocyte response to the fungal antigen.
In contrast, a response to A. fumigatus was not observed uniformly when peripheral blood mononuclear cells from stem cell transplant recipients were tested, even in the presence of ex vivo-generated DC. Hyporesponsiveness could have been due to a low number of circulating A. fumigatusreactive lymphocytes in the post-transplant specimen or to a lymphocyte dysfunction caused by incomplete maturation of the lymphocytes in the early post-transplant period. The latter is less likely, given the responses to Candida obtained in these patients (Table 4 ). Poor reactivity of the patients' cells may preclude the utility of DC-based immunizations in the very early post-transplant period, but with repeated stimulation using fungal antigen-pulsed DC in vitro, expanded fungus-reactive lymphocytes from a pretransplant specimen or from HLA-compatible normal donors could be used for adoptive therapy as has been accomplished for other antigens. 24 The role of DC in normal or pathological responses to Aspergillus has not been determined in vivo in humans. Our data suggest that DC might play a pivotal role in augmenting antifungal immunity through promotion of a type-1 cytokine response, although this was not tested in vivo. DC phagocytosed A. fumigatus conidia, an event that corresponded with activation of DC. Furthermore, conidiapulsed DC stimulated proliferation and Th1-type cytokine production in vitro by autologous lymphocytes. Most importantly, DC generated from progenitors collected prior to transplantation augmented the antifungal proliferative response of autologous lymphocytes obtained from normal donors and from some patients early after transplantation. DC generated ex vivo represent a new therapeutic tool for restoring or amplifying the antifungal immune response of immunocompromised hematopoietic stem cell transplant recipients. Whether induction of cell-mediated immunity to Aspergillus will be sufficient to prevent invasive disease in this population remains to be tested in a clinical study.
